TOPCON

contributes to the enrichment
of human life
through leading-edge technology

“increase in eye disease resulting from global population aging” “concerns for food shortages resulting
from global population growth” “shortage of skilled engineers resulting from globally rising infrastructure demands.”
Topcon is promoting its efforts to solve societal challenges of “healthcare” “agriculture”
and “infrastructure” utilizing DX solutions.

Watch the movie

What’s New

Investor Relations

Notice of Application for Selection of "Prime Market" in the Tokyo Stock Exchange New Market Segments

2021-11-26

Smart Infrastructure

Notice of closure of TShsield portal site

2021-10-29

Investor Relations

FY2021 Q2 Financial Results posted

2021-10-29

Other

Notice of winning the 2021 GOOD DESIGN AWARD

2021-10-25

Investor Relations

TOPCON REPORT 2021 has been issued

2021-10-18

Smart Infrastructure

WARNING NOTICE: Counterfeit versions of TOPCON's 360° prisms (ATP1 and ATP2S)

2021-09-09

Investor Relations

FY2021 Q1 Financial Results posted

2021-07-30

Eye Care

Topcon acquires VISIA Imaging S.r.l, ophthalmic medical device manufacturer in Italy

2021-07-07

Investor Relations

Notice of change (additional appointment) of Representative Director

2021-06-25

About Topcon

Established in 1932 and currently a global company with 80% of sales and 70% of employees from overseas.
Introducing Topcon’s policy, outline and history.

Company Profile

Investor Relations

Introducing Topcon’s efforts toward continuous growth and improvement of mid- and long-term corporate values.

View Information

While life has become convenient by the development of society and industry, our community carries various issues.
Topcon will continue to contribute to an even more rich and sustainable society in familiar areas of “healthcare” “agriculture” and “infrastructure”, the foundations of human life.

Special Contents